In multiple myeloma, CXCL12/CXCR4 signaling has been shown to promote proliferation, migration, invasion, metastasis, chemoresistance, and tumor-induced osteoclastogenesis (192–196). This evidence concerns the gene CXCR4 and neoplasm.